Algorhythm Terminates $1.4M Settlement, Avoids 8M+ Share Dilution
RIME is trading near its 52-week low of $0.177 (0.5% below the low) on elevated volume (6.2× avg).
Summary
Algorhythm terminated a $1.4M Section 3(a)(10) settlement with Continuation Capital, avoiding the issuance of over 8 million shares. This follows the retirement of its Series A preferred stock, signaling continued balance-sheet cleanup. The move removes a significant near-term dilution overhang for a company trading near its 52-week low with a market cap around $3.2 million. The termination also comes after the $23M all-stock Azure Energy acquisition, which already increased share count. Traders should note the company's ongoing financial distress and going concern warning, but this specific action reduces equity supply pressure.
At the time of this announcement, RIME was trading at $0.18 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.2M. The 52-week trading range was $0.18 to $4.58. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.